Cargando…
5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD)
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112576/ http://dx.doi.org/10.1097/01.HS9.0000928320.14894.77 |
_version_ | 1785027650899673088 |
---|---|
author | Callaghan, M. Ataga, K.I. De Franceschi, L. Minniti, C. Balachandran, N. Imbs, D.-.C. Perretti, T. Ramos, J. Sostelly, A. Bartolucci, P. |
author_facet | Callaghan, M. Ataga, K.I. De Franceschi, L. Minniti, C. Balachandran, N. Imbs, D.-.C. Perretti, T. Ramos, J. Sostelly, A. Bartolucci, P. |
author_sort | Callaghan, M. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10112576 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-101125762023-04-19 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) Callaghan, M. Ataga, K.I. De Franceschi, L. Minniti, C. Balachandran, N. Imbs, D.-.C. Perretti, T. Ramos, J. Sostelly, A. Bartolucci, P. Hemasphere Poster Presentations Lippincott Williams & Wilkins 2023-04-10 /pmc/articles/PMC10112576/ http://dx.doi.org/10.1097/01.HS9.0000928320.14894.77 Text en Copyright © 2023 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Poster Presentations Callaghan, M. Ataga, K.I. De Franceschi, L. Minniti, C. Balachandran, N. Imbs, D.-.C. Perretti, T. Ramos, J. Sostelly, A. Bartolucci, P. 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_full | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_fullStr | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_full_unstemmed | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_short | 5612539 TRIAL IN PROGRESS: THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2A CROSSWALK-C TRIAL EVALUATING THE EFFICACY OF CROVALIMAB AS ADJUNCT TREATMENT IN THE PREVENTION OF VASO-OCCLUSIVE EPISODES (VOES) IN PATIENTS (PTS) WITH SICKLE CELL DISEASE (SCD) |
title_sort | 5612539 trial in progress: the randomized, double-blind, placebo-controlled phase 2a crosswalk-c trial evaluating the efficacy of crovalimab as adjunct treatment in the prevention of vaso-occlusive episodes (voes) in patients (pts) with sickle cell disease (scd) |
topic | Poster Presentations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112576/ http://dx.doi.org/10.1097/01.HS9.0000928320.14894.77 |
work_keys_str_mv | AT callaghanm 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT atagaki 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT defranceschil 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT minnitic 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT balachandrann 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT imbsdc 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT perrettit 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT ramosj 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT sostellya 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd AT bartoluccip 5612539trialinprogresstherandomizeddoubleblindplacebocontrolledphase2acrosswalkctrialevaluatingtheefficacyofcrovalimabasadjuncttreatmentinthepreventionofvasoocclusiveepisodesvoesinpatientsptswithsicklecelldiseasescd |